[Advancing acromegaly with low growth hormone levels. Influence of an analog of somatostatin administered in continuous subcutaneous infusion]
- PMID: 2894669
[Advancing acromegaly with low growth hormone levels. Influence of an analog of somatostatin administered in continuous subcutaneous infusion]
Similar articles
-
A comparison among the growth hormone-lowering effects in acromegaly of the somatostatin analog SMS 201-995, bromocriptine, and the combination of both drugs.J Clin Endocrinol Metab. 1986 Jul;63(1):16-9. doi: 10.1210/jcem-63-1-16. J Clin Endocrinol Metab. 1986. PMID: 2872225
-
Effect of high dose somatostatin analogue on growth hormone concentrations in acromegaly.Br Med J (Clin Res Ed). 1988 Mar 12;296(6624):751-2. doi: 10.1136/bmj.296.6624.751-a. Br Med J (Clin Res Ed). 1988. PMID: 2894886 Free PMC article. Clinical Trial. No abstract available.
-
[Long-term treatment of acromegaly with a somatostatin analog].Ugeskr Laeger. 1987 Aug 17;149(34):2263. Ugeskr Laeger. 1987. PMID: 2897734 Danish. No abstract available.
-
[Novel pharmacologic therapies in acromegaly].Orv Hetil. 2002 May 12;143(19 Suppl):1057-62. Orv Hetil. 2002. PMID: 12063860 Review. Hungarian.
-
Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.Neuroendocrinology. 2006;83(3-4):249-57. doi: 10.1159/000095535. Epub 2006 Oct 13. Neuroendocrinology. 2006. PMID: 17047390 Review.